← Back

Nexalin Technology Inc.

Nexalin Technology, Inc. is a medical device company that designs and develops neurostimulation products for treating mental health conditions in the United States and China. Its Generation 1 device uses bioelectronic medical technology to treat anxiety, insomnia, and depression without drugs or psychotherapy. The company also offers Generation 2 and Generation 3 headset devices for depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, chronic pain, Alzheimer's disease, and dementia. It is headquartered in Houston, Texas.

Country
Price · split & dividend adjusted
News & notes moving NXL
United StatesChinaPhilippinesJapan
NXL

Nike Falls 10% on Revenue Miss; ON Semiconductor to Buy Synaptics for $123 a Share

Nike shares fell more than 10% in premarket trading after the company missed revenue expectations against LSEG consensus for its fiscal first quarter, reporting sales down 4% on declines in its China business and announcing plans to lay off staff in 2027. Synaptics shares jumped over 14% and ON Semiconductor shares rose more than 7% following reports that ON Semiconductor will acquire Synaptics for $123 per share in cash, a transaction now valued at $5.7 billion, down from the prior agreement of $7 billion. Nexalin Technology shares dropped over 18% premarket after the medical device company announced a 10-year distribution and manufacturing deal with Inovanexa Medical Technologies on Thursday, clearing its Nexalin Sync neurostimulation device for distribution across seven South American countries. Vylor shares gained slightly after the seeds and genetics company was added to the S&P 500 on Thursday, following its spinoff from Corteva, which will move to the S&P MidCap 400. Seagate Technology and Western Digital shares fell over 11% and 8% respectively after a Nikkei report that Toshiba will double its production capacity for data-center hard disk drives and invest $380 million to expand facilities in the Philippines.
NKE · Capital · Negative Nike missed revenue expectations and reported sales down 4% with China declines and planned layoffs.
ON · Capital · Positive ON Semiconductor will acquire Synaptics for $123 per share in cash, a $5.7 billion transaction.
SYNA · Capital · Positive Synaptics jumped over 14% on reports ON Semiconductor will acquire it for $123 per share in cash.
NXL · Regulation · Neutral Nexalin announced a 10-year distribution/manufacturing deal clearing its neurostimulation device for seven South American countries, yet shares dropped 18%.
WDC · Competition · Negative Toshiba will double data-center HDD production capacity, intensifying competition against Western Digital's HDD business.
6588.JP · Supply · Positive Toshiba is doubling data-center HDD production capacity and investing $380 million to expand Philippines facilities.
Read original ↗
United States
NXL▼

Nexalin Technology Announces 1-for-30 Reverse Stock Split

Nexalin Technology, Inc. announced that its board of directors has approved a 1-for-30 reverse stock split of its common stock to ensure continued compliance with the Nasdaq bid-price rule. The split will become effective on August 28, 2026, at 5:00 pm Eastern Time, and the company's shares are expected to begin trading on a split-adjusted basis on The Nasdaq Capital Market under the ticker symbol "NXL" on August 31, 2026. Every 30 shares of issued and outstanding common stock will be combined into one share, with the par value remaining unchanged at $0.001 per share. No fractional shares will be issued; stockholders entitled to a fractional share will receive a proportional cash payment. Continental Stock Transfer & Trust Co. will serve as the exchange agent, and stockholders holding shares in book-entry or street name will have their positions automatically adjusted.
NXL · Capital · Negative Board approved a 1-for-30 reverse stock split to regain compliance with Nasdaq's bid-price rule, a negative capital-structure event.
Read original ↗
GlobeNewswire·40dRead more →